CI 934

CI 934 구조식 이미지
카스 번호:
91188-00-0
상품명:
CI 934
동의어(영문):
CI 934;PD-114843;Aids007688;Aids-007688;Quinolone cl-934;Merafloxacin (CI-934);1-Ethyl-7-(3-((ethylamino)methyl)pyrrolidin-1-yl)-6,8-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid;1-Ethyl-7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid;3-Quinolinecarboxylic acid, 1-ethyl-7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8-difluoro-1,4-dihydro-4-oxo-;Merafloxacin,frameshifting,SARS-CoV,bacteria,antibacterial,fluoroquinolone,Inhibitor,CI934,gram-positive,inhibit,programmed,coronaviruses,ribosomal,PRF,gram-negative,SARS coronavirus,CI-934
CBNumber:
CB91398664
분자식:
C19H23F2N3O3
포뮬러 무게:
379.4
MOL 파일:
91188-00-0.mol
MSDS 파일:
SDS

CI 934 속성

녹는점
200-220.45 °C
끓는 점
545.8±50.0 °C(Predicted)
밀도
1.304±0.06 g/cm3(Predicted)
저장 조건
Store at -20°C
용해도
DMSO : 11.11 mg/mL (29.28 mM; ultrasonic and adjust pH to 3 with HCl)
물리적 상태
Solid
산도 계수 (pKa)
6.44±0.50(Predicted)
색상
White to off-white

안전

CI 934 C화학적 특성, 용도, 생산

CI 934 준비 용품 및 원자재

원자재

준비 용품


CI 934 공급 업체

글로벌( 26)공급 업체
공급자 전화 이메일 국가 제품 수 이점
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795
ivan@atkchemical.com China 32956 60
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000
marketing@targetmol.com United States 32161 58
Shenzhen Shengda Pharma Limited
755-85269922 +8613424394241
sales@shengdapharm.com CHINA 310 58
InvivoChem
+1-708-310-1919 +1-13798911105
sales@invivochem.cn United States 6391 58
Nantong HI-FUTURE Biology Co., Ltd.
+undefined18051384581
sales@chemhifuture.com China 3135 58
TargetMol Chemicals Inc.

support@targetmol.com United States 38631 58
LEAPCHEM CO., LTD.
+86-852-30606658
market18@leapchem.com China 43340 58
Aladdin Scientific
+1-+1(833)-552-7181
sales@aladdinsci.com United States 52924 58
ShangHai Caerulum Pharma Discovery Co., Ltd. 18149758185 18149758185
sales-cpd@caerulumpharma.com China 3466 58
Shanghai EFE Biological Technology Co., Ltd. 021-65675885 18964387627
info@efebio.com China 9806 58

Copyright 2019 © ChemicalBook. All rights reserved